ArriVent BioPharma, Inc. Common Stock

AVBPNASDAQ • USD
31.34 USD
↘ 0.06 (0.18%)🟢LIVE (AS OF 12:27 PM EDT)
🟢Market: OPEN
Open?$31.45
High?$32.79
Low?$29.59
Prev. Close?$31.39
Volume?201.8K
Avg. Volume?520.8K
VWAP?$31.21
Rel. Volume?0.39x
Bid / Ask
Bid?$27.00 × 100
Ask?$31.72 × 100
Spread?$4.72
Midpoint?$29.36
Valuation & Ratios
Market Cap?1.4B
Shares Out?44.2M
Float?21.7M
Float %?52.5%
P/E Ratio?N/A
P/B Ratio?4.52
EPS?-$3.76
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?12.83Strong
Quick Ratio?12.83Strong
Cash Ratio?1.76Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A▾
P/B?
4.52FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-7.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-54.1%WEAK▾
ROA?
-49.9%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$1.3B
Related Companies
ACRVADCTAKTXACTUAPREARAYBBOTBCABBCYCBDTXBGMSBOLDCCCCCELCCLRBCRDFCSBRCTORDAWNDCTH
News
Profile
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
Employees
77
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.arrivent.com
Listed
2024-01-26
Address
18 CAMPUS BLVD.
NEWTOWN SQUARE, PA 19073-3269
Phone: 240-780-6356
MarketsMoversWatchlist